314 related articles for article (PubMed ID: 19010781)
21. Chaperoning shape-shifting tau in disease.
Ryder BD; Wydorski PM; Hou Z; Joachimiak LA
Trends Biochem Sci; 2022 Apr; 47(4):301-313. PubMed ID: 35045944
[TBL] [Abstract][Full Text] [Related]
22. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
23. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
[TBL] [Abstract][Full Text] [Related]
24. Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.
Shimonaka S; Matsumoto SE; Elahi M; Ishiguro K; Hasegawa M; Hattori N; Motoi Y
J Biol Chem; 2020 Oct; 295(41):13996-14014. PubMed ID: 32759167
[TBL] [Abstract][Full Text] [Related]
25. Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations.
Meyer V; Holden MR; Weismiller HA; Eaton GR; Eaton SS; Margittai M
J Biol Chem; 2016 Jun; 291(23):12271-81. PubMed ID: 27080260
[TBL] [Abstract][Full Text] [Related]
26. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
[TBL] [Abstract][Full Text] [Related]
27. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
28. Tau protein assembles into isoform- and disulfide-dependent polymorphic fibrils with distinct structural properties.
Furukawa Y; Kaneko K; Nukina N
J Biol Chem; 2011 Aug; 286(31):27236-46. PubMed ID: 21659525
[TBL] [Abstract][Full Text] [Related]
29. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.
Barghorn S; Davies P; Mandelkow E
Biochemistry; 2004 Feb; 43(6):1694-703. PubMed ID: 14769047
[TBL] [Abstract][Full Text] [Related]
30. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
[TBL] [Abstract][Full Text] [Related]
31. Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation.
Sun KT; Patel T; Kang SG; Yarahmady A; Srinivasan M; Julien O; Heras J; Mok SA
ACS Chem Neurosci; 2023 Dec; 14(24):4282-4297. PubMed ID: 38054595
[TBL] [Abstract][Full Text] [Related]
32. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: A comparative study.
Jangholi A; Ashrafi-Kooshk MR; Arab SS; Riazi G; Mokhtari F; Poorebrahim M; Mahdiuni H; Kurganov BI; Moosavi-Movahedi AA; Khodarahmi R
Arch Biochem Biophys; 2016 Nov; 609():1-19. PubMed ID: 27638048
[TBL] [Abstract][Full Text] [Related]
33. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.
Nacharaju P; Lewis J; Easson C; Yen S; Hackett J; Hutton M; Yen SH
FEBS Lett; 1999 Mar; 447(2-3):195-9. PubMed ID: 10214944
[TBL] [Abstract][Full Text] [Related]
34. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.
Kaniyappan S; Tepper K; Biernat J; Chandupatla RR; Hübschmann S; Irsen S; Bicher S; Klatt C; Mandelkow EM; Mandelkow E
Mol Neurodegener; 2020 Jul; 15(1):39. PubMed ID: 32677995
[TBL] [Abstract][Full Text] [Related]
35. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
36. Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils.
Nizynski B; Nieznanska H; Dec R; Boyko S; Dzwolak W; Nieznanski K
PLoS One; 2018; 13(7):e0201182. PubMed ID: 30024984
[TBL] [Abstract][Full Text] [Related]
37. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.
Schweers O; Schönbrunn-Hanebeck E; Marx A; Mandelkow E
J Biol Chem; 1994 Sep; 269(39):24290-7. PubMed ID: 7929085
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and biophysical features of disease-associated tau mutants V363A and V363I.
De Luigi A; Colombo L; Russo L; Ricci C; Bastone A; Cimini S; Tagliavini F; Rossi G; Cantù L; Del Favero E; Salmona M
Biochim Biophys Acta Proteins Proteom; 2022 Mar; 1870(3):140755. PubMed ID: 34999006
[TBL] [Abstract][Full Text] [Related]
39. Impact of the Hereditary P301L Mutation on the Correlated Conformational Dynamics of Human Tau Protein Revealed by the Paramagnetic Relaxation Enhancement NMR Experiments.
Kawasaki R; Tate SI
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486218
[TBL] [Abstract][Full Text] [Related]
40. Side chain-dependent stacking modulates tau filament structure.
Margittai M; Langen R
J Biol Chem; 2006 Dec; 281(49):37820-7. PubMed ID: 17023423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
